Handelsavisen
prelaunch
Companies Healthcare PREV.BO
PR
PREV.BO BSE (India) Advanced Medical Equipment & Technology

Prev.Bo

$404,10
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
0,23 %
Op margin
32,0 %
ROE
17,2 %
Net margin
28,8 %
Debt / equity
0,00
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

PREV.BO operates in the Advanced Medical Equipment & Technology industry, providing specialized medical devices and technologies to healthcare providers and institutions.

Business. PREV.BO operates in the Advanced Medical Equipment & Technology industry, providing specialized medical devices and technologies to healthcare providers and institutions.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
17,2 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning PREV.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to PREV.BO. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    PREV.BO operates in the Advanced Medical Equipment & Technology industry, providing specialized medical devices and technologies to healthcare providers and institutions.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryAdvanced Medical Equipment & Technology
    AI synthesis
    GENERATED

    The company maintains a strong liquidity position, with a current ratio of 14.38, indicating a significant buffer of current assets over current liabilities. It holds INR 109.42 million in cash and equivalents, and has no long-term debt, which supports a debt-to-equity ratio of 0.0. The company's free cash flow of INR 168.90 million and operating cash flow of INR 148.17 million further reinforce its liquidity position.

    In terms of profitability, the company demonstrates a return on equity (ROE) of 17.2% and a return on assets (ROA) of 16.13%. These metrics suggest that the company is effectively utilizing its equity and asset base to generate returns, which is a positive sign for investors. The operating income of INR 201.84 million and net income of INR 181.55 million indicate a healthy margin structure.

    The company's revenue is concentrated in a single business segment, as disclosed in its financials, with no geographic breakdown provided in the available data. This lack of geographic diversification could pose a concentration risk, although the company's strong financial position may mitigate some of these concerns.

    Looking ahead, the company is expected to maintain its growth trajectory, supported by its strong cash flow and profitability. The capital expenditure of INR -19.68 million suggests that the company is investing in its operations, which could drive future growth. The absence of immediate liquidity or dilution flags further supports a stable outlook for the company.

    The company's risk profile is characterized by low liquidity and dilution risks. The absence of long-term debt and the presence of substantial cash reserves reduce the likelihood of liquidity stress. Additionally, there are no immediate filing-based dilution flags, indicating that the company is not currently planning to issue additional shares that could dilute existing shareholders.

    Recent events and filings do not indicate any significant changes in the company's operations or financial position. The company's financials are consistent with its historical performance, and there are no notable events or transcripts that suggest a shift in strategy or operations.

    Key takeaways
    • The company has a strong liquidity position with a current ratio of 14.38 and no long-term debt.
    • It demonstrates high profitability with a return on equity of 17.2% and a return on assets of 16.13%.
    • The company's revenue is concentrated in a single business segment, which could pose a concentration risk.
    • The company is expected to maintain its growth trajectory, supported by strong cash flow and profitability.
    • The company's risk profile is characterized by low liquidity and dilution risks.
    • "margin_outlook_rationale": "The company's strong operating and net income margins suggest that it is effectively managing its costs and generating healthy profits.",

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $404,10
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $1.06B
    Net cash
    $109.4M
    Current ratio
    14.4
    Debt / equity
    0.0
    ROA
    16.1%
    ROE
    17.2%
    Cash conversion
    82.0%
    CapEx / revenue
    -3.1%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin32,0 %Above P75
    Net Margin28,8 %Above P75
    ROE17,2 %Above P75
    Capex / Rev-3,1 %Above median
    D/E0,00Above median
    Cash Conv0,82Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • PREV.BO Market data — financials · 2026-05-29

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    PREV.BOCanonical
    BSE (India) · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage